Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improved Language Acquisition Through Neuromodulation
NCT00102284Phase 4Terminated
- Sponsor
- Universitätsklinikum Münster
- Start
- Mar 2004
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of pergolide, rivastigmine, modafinil, levodopa, sponsored by Universitätsklinikum Münster. Started Mar 2004; status: terminated.
02
Drugs
pergoliderivastigminemodafinillevodopa
Beyond the preview
Go deeper on NCT00102284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102284.